Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response
Article in Epigenomics (March 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Epigenomics (March 2024)
Article in Pharmaceutics (June 2023)
Article in International Journal of Molecular Sciences (February 2023)